Covaxin covid-19 vaccine shows robust immune response
India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials. A detailed immunogenicity response of the first
India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials. A detailed immunogenicity response of the first
New Delhi state of India is seeing an increase in new cases of covid-19 coronavirus disease. Navratri, Dusshera and Durga Pooja celebrations have a definite
Social distancing may influence the microbiome is by limiting the transmission of antibiotic resistant microbes between people and the exchange of resistance genes between microbes.
The number of people coronavirus disease 2019 (COVID-19) is rising with more cases in the U.S. (5M according to the Centers for Disease Control and
Russia has developed the first vaccine against the coronavirus. The announcement was made by President Vladimir Putin during a televised video conference call with government
Hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients. WHO accepted the recommendation from the Solidarity Trial’s International Steering
A single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six rhesus macaques from pneumonia caused by the virus, according to National
U.S. Food and Drug Administration approved Tabrecta (capmatinib) for the treatment of adult patients with non-small cell lung cancer (NSCLC) that has spread to other
U.S. Food and Drug Administration authorized the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing. Specifically, the FDA issued
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its new